These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 24759621)
1. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma. Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation. Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344 [TBL] [Abstract][Full Text] [Related]
3. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling. Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455 [TBL] [Abstract][Full Text] [Related]
4. XAF1 is frequently methylated in human esophageal cancer. Chen XY; He QY; Guo MZ World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195 [TBL] [Abstract][Full Text] [Related]
5. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer]. Yan WJ; Guo MZ; Yang YS Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development. Wang Y; Zhang Y; Herman JG; Linghu E; Guo M Oncotarget; 2017 Sep; 8(41):70035-70048. PubMed ID: 29050260 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling. Liu Y; Zhang M; He T; Yang W; Wang L; Zhang L; Guo M Clin Epigenetics; 2020 Feb; 12(1):22. PubMed ID: 32041673 [TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling. Yang W; Guo C; Herman JG; Zhu C; Lv H; Su X; Zhang L; Zhang M; Guo M Clin Epigenetics; 2022 Dec; 14(1):164. PubMed ID: 36461092 [TBL] [Abstract][Full Text] [Related]
12. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. Zhang M; Linghu E; Zhan Q; He T; Cao B; Brock MV; Herman JG; Xiang R; Guo M Oncotarget; 2016 Apr; 7(14):17957-69. PubMed ID: 26919254 [TBL] [Abstract][Full Text] [Related]
13. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer. Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898 [TBL] [Abstract][Full Text] [Related]
14. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
15. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer. Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815 [TBL] [Abstract][Full Text] [Related]
18. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer. Li Z; Chang X; Dai D; Deng P; Sun Q Oncol Rep; 2014 Apr; 31(4):1661-8. PubMed ID: 24573726 [TBL] [Abstract][Full Text] [Related]
19. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma. Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]